Sirolimus Eye Drops(Haoji Medical)

西罗莫司滴眼液（好吉医药）

Report date: 2026/03/04 20:01:44

Base Information

Drug NameSirolimus Eye Drops(Haoji Medical)
Drug Alias Name雷帕霉素西罗莫斯西罗莫司滴眼液（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionmTOR Complex 2 inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors
TargetsMammalian target of Rapamycin (mTORC1)mTOR Complex 2
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFuzhou Haoji Medical Technology Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFuzhou Haoji Medical Technology Development Co Ltd
Inactive CompaniesN/A
Active IndicationsXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG